These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2480027)

  • 1. [Radioimmunometric determination of histamine in myeloproliferative syndromes].
    Bettelheim P; Valent P
    Wien Klin Wochenschr; 1989 Oct; 101(20):706-10. PubMed ID: 2480027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical conference: Histaaminemia in myeloproliferative syndromes].
    Cadiou M; Ruff F; Meunier F; Attalah N; Bernadou A; Zittoun R; Parrot JL; Bousser J
    Nouv Rev Fr Hematol; 1975; 15(2):261-9. PubMed ID: 126436
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders.
    Passamonti F; Vanelli L; Malabarba L; Rumi E; Pungolino E; Malcovati L; Pascutto C; Morra E; Lazzarino M; Cazzola M
    Haematologica; 2003 Oct; 88(10):1123-9. PubMed ID: 14555308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interleukin-3: a preclinical study].
    Valent P; Geissler K; Bettelheim P
    Wien Klin Wochenschr; 1989 Oct; 101(19):652-63. PubMed ID: 2482586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood histamine in the differential diagnosis of myeloid splenomegaly (osteomyelofibrosis) and other myeloproliferative disorders.
    Gingold N
    Rev Roum Med; 1974; 12(1):15-8. PubMed ID: 4533361
    [No Abstract]   [Full Text] [Related]  

  • 6. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
    Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
    Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glycosaminoglycans in leukocytes in myeloproliferative disorders].
    Kharchenko MF; Shatskaia TL; Ostroumova SS; Rybakova LP; Shcherbakova EG
    Vopr Med Khim; 1984; 30(4):86-91. PubMed ID: 6594825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: quantification of CD34+ cells by polymerase chain reaction.
    Oppliger Leibundgut E; Brunold C; Marti D; Horn MP; Seiler C; Schroeder V; Schmid JP; Tobler A; Zwicky C
    Haematologica; 2005 Jul; 90(7):875-80. PubMed ID: 15996924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
    Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
    Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of determining the amino terminal fragment of procollagen III in myeloproliferative disorders].
    Najean Y; Poirier O; Arrago JP
    Nouv Rev Fr Hematol (1978); 1987; 29(2):123-7. PubMed ID: 3615194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous erythroid colony formation in myeloproliferative diseases does not depend on T cells.
    Robak T; Hast R; Goldman JM
    Exp Hematol; 1986 Mar; 14(3):197-201. PubMed ID: 3485053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood histamine level in chronic myeloproliferative diseases; a review].
    Gingold N
    Onkologie; 1979 Apr; 2(2):70-4. PubMed ID: 392372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Granulocyte clearance and granulocyte kinetics in myeloproliferative syndromes].
    Jungi WF; Meuret G; Senn HJ
    Schweiz Med Wochenschr; 1974 Jan; 104(4):133-5. PubMed ID: 4521299
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma fibronectin in idiopathic myelofibrosis and related chronic myeloproliferative disorders.
    Hasselbalch H; Clemmensen I
    Scand J Clin Lab Invest; 1987 Sep; 47(5):429-33. PubMed ID: 3477850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein.
    Sarmiento EU; Espiritu BR; Gleich GJ; Thomas LL
    J Immunol; 1995 Aug; 155(4):2211-21. PubMed ID: 7543541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of histamine in myeloproliferative disease.
    Gilbert HS; Warner RR; Wasserman LR
    Blood; 1966 Dec; 28(6):795-806. PubMed ID: 5959473
    [No Abstract]   [Full Text] [Related]  

  • 19. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
    Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
    Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.